Cargando…

Combination Drug Delivery Approaches in Metastatic Breast Cancer

Disseminated metastatic breast cancer needs aggressive treatment due to its reduced response to anticancer treatment and hence low survival and quality of life. Although in theory a combination drug therapy has advantages over single-agent therapy, no appreciable survival enhancement is generally re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jun H., Nan, Anjan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350970/ https://www.ncbi.nlm.nih.gov/pubmed/22619725 http://dx.doi.org/10.1155/2012/915375

Ejemplares similares

Drug delivery approaches for breast cancer
por: Singh, Santosh Kumar, et al.
Publicado: (2017)

Nano drug delivery systems improve metastatic breast cancer therapy
por: Zhu, Runqi, et al.
Publicado: (2021)

Novel combinations for the treatment of metastatic breast cancer
por: Vahdat, Linda T.
Publicado: (2010)

Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy
por: Huang, Mian, et al.
Publicado: (2023)

Combination Strategies of Checkpoint Immunotherapy in Metastatic Breast Cancer
por: Liu, Zhi Bing, et al.
Publicado: (2020)

Drug Delivery Approaches for the Treatment of Cervical Cancer
por: Ordikhani, Farideh, et al.
Publicado: (2016)

'Omic approaches to preventing or managing metastatic breast cancer
por: Griffith, Obi L, et al.
Publicado: (2011)

Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer
por: Cipriano, Élia, et al.
Publicado: (2021)

Functionalized liposomes for targeted breast cancer drug delivery
por: Nel, Janske, et al.
Publicado: (2023)

Nanoparticle-Mediated Therapeutic Agent Delivery for Treating Metastatic Breast Cancer—Challenges and Opportunities
por: Li, Yunfei, et al.
Publicado: (2018)

Gold Nanoparticle Approach to the Selective Delivery of Gene Silencing in Cancer—The Case for Combined Delivery?
por: Mendes, Rita, et al.
Publicado: (2017)

Oral fluoropyrimidines among the new drugs for patients with metastatic breast cancer
por: Leonard, R C F
Publicado: (2001)

Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue
por: Gote, Vrinda, et al.
Publicado: (2021)

Injectable Nano Drug Delivery Systems for the Treatment of Breast Cancer
por: Kafle, Urmila, et al.
Publicado: (2022)

Current approaches to the management of Her2-negative metastatic breast cancer
por: Gogineni, Keerthi, et al.
Publicado: (2012)

Metastatic Heterogeneity of Breast Cancer: Companion and Theranostic Approach in Nuclear Medicine
por: Montemagno, Christopher, et al.
Publicado: (2020)

Metastatic ER+ Breast Cancer: Mechanisms of Resistance and Future Therapeutic Approaches
por: Raheem, Farah, et al.
Publicado: (2023)

Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems
por: Kydd, Janel, et al.
Publicado: (2017)

Combination of Nanomaterials in Cell-Based Drug Delivery Systems for Cancer Treatment
por: Tang, Lu, et al.
Publicado: (2021)

Combination of drugs and carriers in drug delivery technology and its development
por: Du, Ying, et al.
Publicado: (2019)

Novel Drugs and Combination Therapies for the Treatment of Metastatic Melanoma
por: Vennepureddy, Adarsh, et al.
Publicado: (2016)

Efficacy of Bevacizumab-Capecitabine in Combination for the First-Line Treatment of Metastatic Breast Cancer
por: Dyar, Stephen, et al.
Publicado: (2011)

Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future Directions
por: David, Steven, et al.
Publicado: (2022)

Current and New Novel Combination Treatments for Metastatic Triple-Negative Breast Cancer
por: Pauls, Mehrnoosh, et al.
Publicado: (2022)

HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer
por: Raju, Ganji Seeta Rama, et al.
Publicado: (2023)

Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting
por: Lv, Li, et al.
Publicado: (2021)

Lipid-Based Nanomaterials for Drug Delivery Systems in Breast Cancer Therapy
por: Rethi, Lekshmi, et al.
Publicado: (2022)

Use of Salmonella Bacteria in Cancer Therapy: Direct, Drug Delivery and Combination Approaches
por: Badie, Fereshteh, et al.
Publicado: (2021)

Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer
por: Page, David B., et al.
Publicado: (2019)

Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis
por: Subhan, Md Abdus, et al.
Publicado: (2023)

Jadomycins: A potential chemotherapy for multi‐drug resistant metastatic breast cancer
por: Bonitto, Esther P., et al.
Publicado: (2021)

Bio-Targets and Drug Delivery Approaches
por: Kaushik, Meetu
Publicado: (2017)

Tuberculosis chemotherapy: current drug delivery approaches
por: du Toit, Lisa Claire, et al.
Publicado: (2006)

Drug combination and repurposing for cancer therapy: the example of breast cancer
por: Correia, Ana Salomé, et al.
Publicado: (2021)

Evolving Approaches to Metastatic Breast Cancer Patients Pre-treated with Anthracycline and Taxane
por: Saji, Shigehira
Publicado: (2013)

A Combined Self-Assembled Drug Delivery for Effective Anti-Breast Cancer Therapy
por: Wang, Hairong, et al.
Publicado: (2021)

Mechanisms of Resistance to Chemotherapy in Breast Cancer and Possible Targets in Drug Delivery Systems
por: Lainetti, Patrícia de Faria, et al.
Publicado: (2020)

Chitosan-Based Nanoparticles of Targeted Drug Delivery System in Breast Cancer Treatment
por: Herdiana, Yedi, et al.
Publicado: (2021)

Advances in Aptamers-Based Applications in Breast Cancer: Drug Delivery, Therapeutics, and Diagnostics
por: Gholikhani, Tooba, et al.
Publicado: (2022)

Chitosan-Based Nano-Smart Drug Delivery System in Breast Cancer Therapy
por: Herdiana, Yedi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jtjeosbflu0gq38n8la0kdsb7l